Header
 
Login
 

Privatsphäre-Einstellungen

Wir verwenden Cookies auf unserer Website. Einige von ihnen sind unerlässlich, während andere uns helfen, diese Website und Ihre Erfahrungen zu verbessern.

Notwendig Statistik Marketing
Auswahl bestätigen
Weitere Einstellungen

Hier finden Sie eine Übersicht aller verwendeten Cookies. Sie können ganzen Kategorien Ihre Zustimmung geben oder weitere Informationen anzeigen und bestimmte Cookies auswählen.

Alle auswählen
Auswahl bestätigen
Notwendig Cookies
Wesentliche Cookies ermöglichen grundlegende Funktionen und sind für die ordnungsgemäße Funktion der Website erforderlich.
Statistik Cookies
Statistik-Cookies sammeln anonym Informationen. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing Cookies
Marketing-Cookies werden von Werbekunden oder Publishern von Drittanbietern verwendet, um personalisierte Anzeigen zu schalten. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen
Zurück

Ihr Suchergebnis

Sie recherchieren derzeit unangemeldet.
Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Handler N.

In der Rubrik Zeitschriften haben wir 5 Beiträge für Sie gefunden

  1. Merken

    How to conduct successful forced degradation studies – Scope and regulatory requirements

    Rubrik: GMP / GLP / GCP

    (Treffer aus pharmind, Nr. 01, Seite 55 (2020))

    Buschmann H | Handler N

    How to conduct successful forced degradation studies – Scope and regulatory requirements / PART III*Part I of this article see Pharm. Ind. 2019;81(9):1192–6, Part II see Pharm. Ind. 2019;81(11):1481–9. · Buschmann H, Handler N · RD&C Research, Development & Consulting GmbH, Vienna, Austria
    The requirements for conducting forced degradation studies are based on guidelines and recommendations of the International Council on Harmonisation (ICH) and national regulatory bodies like the FDA, EMA and ANVISA. Stability assessment is crucial for drug substance (DS) and drug product (DP), as impurities and degradation products may appear due to chemical breakdown leading to product failure. In-depth stability assessment including long-term (12 months) or accelerated (6 months) stability studies have impact on the current heavy time constraints of the drug development process and may increase the time to get the product to market. Therefore, beside data from forced degradation studies, complementing ...

  2. Merken

    How to conduct successful forced degradation studies – Scope and regulatory requirements

    Rubrik: GMP / GLP / GCP

    (Treffer aus pharmind, Nr. 11, Seite 1481 (2019))

    Buschmann H | Handler N

    How to conduct successful forced degradation studies – Scope and regulatory requirements / Part II*Part I of this article see Pharm. Ind. 2019;81(9):1192–1196. · Buschmann H, Handler N · RD&C Research, Development & Consulting GmbH, Vienna und , Austria
    Forced degradation conditions represent the exposure of a drug substance (DS) or drug product (DP) to stress conditions more severe than accelerated conditions which result in relevant degradation products. Well-designed and -applied forced degradation is a useful tool in predicting drug stability, which is an essential critical parameter and has an impact on purity, potency, and safety of the DP. For instance, changes in drug stability may result in a decrease of the active substance or the formation of toxic degradation products. Currently, several guidelines provide general recommendations and guidance on forced degradation studies, but none of the guidelines gives ...

  3. Merken

    How to conduct successful forced degradation studies – Scope and regulatory requirements

    Rubrik: GMP / GLP / GCP

    (Treffer aus pharmind, Nr. 09, Seite 1192 (2019))

    Buschmann H | Handler N

    How to conduct successful forced degradation studies – Scope and regulatory requirements / Part I · Buschmann H, Handler N · RD&C Research, Development & Consulting GmbH, Vienna und , Austria
    The chemical stability of pharmaceutical molecules is a matter of great concern as it affects safety and efficacy of drug products (DP) on the one hand, and involves considerable cost, time consumption and competitiveness on the other. Stability testing evaluates the effect of intrinsic drug properties and environmental factors on the quality of a drug substance (DS) or a formulated DP, and is utilized to predict the shelf life, to determine proper storage conditions and to suggest labeling instructions. Meaningful product-expiration dates are obtained after thorough, scientifically designed studies using specific stability indicating assays and appropriate, validated analytical methods, thorough ...

  4. Es gibt 2 weitere Treffer zu Ihrer Anfrage[ Alle Treffer dieser Rubrik anzeigen ]